Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed With Favourable Risk Prostate Cancer [START]

NCT00499174 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00499174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00499174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed With Favourable Risk Prostate Cancer [START]
Lead sponsor
NCIC Clinical Trials Group
Phase
Not applicable
Overall status
Terminated
Start date
December 6, 2007
Completion date
January 10, 2013
Enrollment
180 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer